American Healthcare REIT price target raised to $37 from $36 at Morgan Stanley

Morgan Stanley analyst Ronald Kamdem raised the firm’s price target on American Healthcare REIT (AHR) to $37 from $36 and keeps an Overweight rating on the shares. The firm updated estimates to reflect Q4 earnings and mark to market the multiple based on where healthcare peers have traded, noting that it updated its FY25 and FY26 FFO per share forecasts to $1.57 and $1.77 from $1.63 and $1.78, respectively.